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The American University in Cairo 
ABSTRACT 
Isolation, Propagation and Characterization of Mouse Testis-Derived Mesenchymal 
Stromal Cells 
By: Mai Omar Abdul Rahman  
Under the supervision of: Dr. Asma Amleh 
Mesenchymal Stromal/Stem Cells (MSCs) are considered promising tools for 
regenerative therapy. MSCs are multipotent cells that have been successfully isolated 
from different species and tissues. Although few studies have reported the isolation of 
MSCs from the testis, there are no reports on their isolation from the mouse, despite its 
close genetic similarity to humans. Since the testis is a heterogeneous population, 
enriching for MSCs will aid in the generation of homogeneous populations from early 
passages. The aim of our work was to utilize the mouse model for the isolation, 
propagation and subsequent characterization of testis-derived MSCs (tMSCs).  
To achieve this aim, we harvested testes from 12 male mice and generated single-cell 
suspensions using a two-step enzymatic digestion technique. Next, we employed a 
laminin-based technique to enrich for MSCs. The isolated cells were cultured in vitro and 
growth kinetics was assessed by calculating the Population Doubling Time (PDT). To 
characterize the isolated cells, Reverse Transcription-Polymerase Chain Reaction (RT-
PCR) was performed on MSC markers (CD44, CD73 and CD29), hematopoietic cell 
marker (CD45), the pluripotency markers Nanog and Oct4 and the germ cell marker 
Vasa. Also, the percentages of cells expressing CD44 and CD45 were assessed by 
immunophenotyping using flow cytometry. 
Successful cultures of tMSCs were established, and the early passages exhibited high 
proliferation patterns with average PDT 47.7 hours. RT-PCR data, confirmed by 
Immunophenotyping, revealed the positive expression of CD44 and the negative 
expression of CD45 in tMSCs. In addition, tMSCs expressed CD73 and CD29 at the 
transcript level. Loss of the fibroblast-like morphology in late passages together with the 
increase in PDT and the decrease in expression levels of CD73 and CD29 suggested that 
tMSCs started to undergo phenotypic divergence. As for the pluripotency markers, 
tMSCs were found to express Nanog but not Oct4. Interestingly, a significant variation in 
the expression patterns of different Nanog variants was observed in the isolated cells. The 
lack of Vasa expression suggested that tMSCs are, most likely, not of germ cell origin. 
To our knowledge, this is the first study to report the isolation of Mesenchymal Stromal 
Cells from the mouse testis. Based on our findings, tMSCs possess characteristics and 
marker profiles similar to that of MSCs, which makes them a potentially valuable tool in 
cell therapy. 
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1. Literature Review 
 
1.1.Stem Cells 
 Stem cells are unspecialized cell types which have the intrinsic capability of self-
renewal to generate more stem cells and the ability to differentiate into other more 
specialized cell types with specific functions (Verfaillie, 2009). Self renewal can be 
achieved through symmetrical or asymmetrical cell divisions; symmetrical cell division 
occurs when the cell divides giving rise to two identical stem cells of equal differentiation 
capabilities similar to the parent cell. On the other hand, asymmetrical division occurs 
more dominantly in adult tissues where a stem cell divides into two daughter cells; one 
identical to the mother stem cells and one committed to a particular differentiation 
pathway. This kind of division replenishes the pool of stem cells while producing more 
differentiated tissue-specific cells (Shenghui et al., 2009).  
 There are different types of stem cells in different tissues and organs and each 
type of stem cells has its unique properties. Stem cells can be classified either according 
to their differentiation potential or their source (Can, 2008). Stem cells are classified 
according to their differentiation capacities into four types; totipotent, pluripotent, 
multipotent and unipotent. While totipotent cells are capable of generating the embryo 
proper and supporting its implantation, pluripotent cells produce the embryo but are not 
competent for establishing implantation (Mitalipov and Wolf, 2009). On the other hand, 
multipotent stem cells are restricted in their development to certain subtypes of cell 
lineages. Mesenchymal multipotent stem cells (MSCs) can differentiate into cells of the 
mesodermal origin (Zuk et al., 2001). Finally, unipotent stem cells develop into one type 
of specialized cells like spermatogonial stem cells generating sperms (Ko et al., 2009). 
 Stem cells are also classified according the developmental stage or the source 
from which they were isolated into two major types; embryonic stem cells (ESCs) and 
adult stem cells. ESCs are pluripotent in nature and they can be derived from the inner 
cell mass (ICM) of early embryos. Their pluripotent properties make them capable of 
differentiating into any cell type in the body (Puri and Nagy, 2012). Adult stem cells are 
the type of stem cells present in adult tissues of the body and they possess different 
properties and potentials. Adult stem cells are committed to tissue repair following injury 
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and tissue regeneration during normal cellular turnover (Wei et al., 2013). To date, 
multiple types of adult stem cells have been isolated. Bone marrow mesenchymal 
stromal/stem cells are the most common type of adult stem cells, there are also brain stem 
cells, skeletal muscle stem cells, liver stem cells and many others (Passier and 
Mummery, 2003). 
 
1.2.Mesenchymal Stromal /Stem Cells 
 Mesenchymal Stem cells are unique cell types which constitute a rare population 
in the stem cell niche of adult tissues. They have captured the interest of biomedical 
researchers over the past 10-15 years because of their unequivocal properties. MSC, are 
referred to as “mesenchymal” because of their ability to differentiate into cells of the 
mesoderm which stimulated intensive investigation into their role in tissue regeneration 
(Keating, 2012). They were first described by Friedenstein et al.  as a subpopulation of 
the bone marrow which possesses osteogenic potentiality (Friedenstein et al., 1968). 
Many studies emerged after Friedenstein’s work reporting the isolation of MSCs from 
different tissues; they were successfully isolated from adipose tissue (Zuk et al., 2002), 
umbilical cord blood (Erices et al., 2000), dental pulp (Gronthos et al., 2000), synovial 
membrane (De Bari et al., 2001) and even from breast milk (Patki et al., 2010).  
 Although “Mesenchymal Stem Cells” is a commonly utilized terminology to 
define these cell types, “Mesenchymal Stromal Cells” is considered a more appropriate 
one since these cells comprise a heterogeneous population of cells which contain stem 
cells together with other cell types (Horwitz et al., 2005).  
 
1.3.Characteristics of MSCs 
 In 2006, the International Society for Cellular Therapy proposed a set of 
minimum criteria for human MSCs. These criteria included plastic adherence and in vitro 
trilineage differentiation into adipogenic, chondrogenic, and osteogenic cells. Additional 
requirements included cell surface expression of Cluster of Differentiation markers; 
CD105 (endoglin, SH2), CD73 (ecto-5′-nucleotidase), and CD90 (Thy1) and the absence 
of the hematopoietic markers, CD45, CD19 or CD79, CD14 or CD11b, and HLA-DR 
(Dominici et al., 2006). However, these criteria were found constraining as different 
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populations of MSCs have been isolated from different tissues each of which possesses 
its own unique properties (Keating, 2012). Also, the proposed criteria are not entirely 
valid across different species. In mouse models, MSCs exhibit different marker 
expression profiles and culture characteristics not only from the human MSCs, but also 
between strains (Peister et al., 2004; Sung et al., 2008). 
 
1.3.1. Expansion patterns of MSCs in vitro 
  Mesenchymal stem cells are spindle-shaped fibroblast-like cells which are 
capable of forming colonies of fibroblasts (Colony Forming Unit Fibroblasts or CFU-F) 
(Friedenstein et al., 1970; Li et al., 2005). To utilize MSCs in clinical settings, it is 
important to study the expansion patterns of these cells in vitro in order to obtain 
sufficient quantities for therapeutic uses. The cell cycle is an ordered and highly 
organized process that is committed to the precise duplication and transmission of genetic 
information among different cell generations (Israels and Israels, 2001). Primary 
mammalian somatic cells have the capacity to expand in vitro for an estimated 50 
population doublings, after which the cultures stop expanding, this phenomenon is 
termed Hayflick’s limit or more commonly known as “replicative senescence” (Hayflick 
and Moorhead, 1961). Although stem cells have the capacity to regenerate themselves 
continuously in the body, they show time-limited proliferation and differentiation 
potential in an ex-vivo setting. They are subject to the Hayflick limit (DiGirolamo et al., 
1999; Jiang et al., 2002a; Izadpanah et al., 2005). It was proposed that early passages 
MSCs display a population doubling time (PDT) of 24–48 hours (hr). However, this PDT 
is variable depending on the culture media and passage number (Safford and Rice, 2005; 
Izadpanah et al., 2006). Actually, the duration of the cell cycle increases significantly 
with prolonged cultures to as long as 150 hr. in MSC cultures of human and non human 
primate MSCs (Bonab et al., 2006). 
 Mesenchymal stem cell show highly variable culturing patterns among different 
populations. This variability has posed a struggle to compare results from different 
groups. The variability has been mainly attributed to the culture parameters in terms of 
the number of passages, the culture media, cell confluence and even plastic surface 
quality could influence the behavior of MSCs in culture (Barrilleaux et al., 2006).  
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 Historically, the culture medium used to grow MSCs was simple and composed of 
basal culture medium (i.e. Dulbecco’s Modified Eagle’s Medium (DMEM) or Minimum 
Essential Medium alpha (MEM-α)) supplemented with fetal bovine serum (FBS) with or 
without additional growth factors (i.e. basic fibroblast growth factor (bFGF)). Despite the 
fact that the serum containing formulations provided successful and robust expansion of 
MSC, there is an increased trend towards using low or serum free culture media because 
of several problems associated with the use of FBS. Serum holds the risk of 
contamination with pathogens, not to mention the significant lot-to-lot variability that 
could infer variability in experimental results like differentiation, proliferation, 
proteomics and genomics (Spees et al., 2004; Dimarakis and Levicar, 2006; Mannello 
and Tonti, 2007; Chase et al., 2010). Also, several growth factors and cytokines are 
reported to be used in culturing MSCs and maintaining its “stemness” state. Leukemia 
inhibitory factor  and fibroblast growth factors (FGFs) are among the different important 
factors which have drawn particular interest because of their proven roles in either 
maintaining undifferentiated mesenchymal tissue or in the self renewal process of other 
types of stem cells (Metcalf, 2003; Zaragosi et al., 2006).  
 Many studies report that human MSCs derived from the marrow undergo 
senescence during prolonged culturing. Signs of senescence usually involve 
morphological changes, decreased differentiation potential and shortening of the mean 
telomere length. The mean telomere length plays an important role in cell senescence as a 
result of decreased telomerase activity (Bonab et al., 2006). It has previously been 
reported that cultures of MSCs derived from the bone marrow and adipose tissue 
underwent morphological alteration upon senescence associated with a decline in 
multipotency potential and a marked decrease in telomerase activity, these features 
seemed to occur progressively with multiple passaging (Izadpanah et al., 2005). 
 
1.3.2. Surface markers of mesenchymal stem cells 
 Mesenchymal stem cells are usually identified phenotypically by the concomitant 
expression of certain cell surface markers. Although MSCs express a number of markers, 
unfortunately, none of them are specific to MSCs. It is generally agreed that there is a 
panel of negative markers which adult human MSCs do not express; the hematopoietic 
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markers CD45 (a marker for all hematopoietic cells), CD34 (Hematopoietic progenitor 
cell antigen), CD117 (a hematopoietic stem/progenitor cell marker), CD14, or CD11b (an 
immune cell marker). Also, they were found to lack the expression of the costimulatory 
molecules CD80 (B lymphocyte activation antigen), CD86 (T-lymphocyte activation 
antigen), CD40 (Tumor necrosis factor receptor superfamily member 5), the adhesion 
molecules CD31 (platelet/endothelial cell adhesion molecule [PECAM]-1), CD18 
(leukocyte function-associated antigen-1 [LFA-1]) and CD56 (neuronal cell adhesion 
molecule-1). The lack of expression of these markers confirms the undifferentiated state 
of MSCs. On the other hand, there is no consensus regarding definitive positive markers 
for MSCs. A myriad of markers has been reported by different groups depending on the 
tissue of origin or on the species. However, it was found that MSCs can express CD44, 
CD29 (Integrin beta-1), CD105 (Endoglin), CD73 (ecto-5'-nucleotidase), CD90 (Thy-1), 
CD71 (Transferrin receptor protein 1 or TfR1), and Stro-1 as well as the adhesion 
molecules CD106 (vascular cell adhesion molecule [VCAM]-1) and CD166 (activated 
leukocyte cell adhesion molecule [ALCAM]) (Conget and Minguell, 1999; Pittenger et 
al., 1999; Sordi et al., 2005). 
 CD105 is the TGF-beta receptor III, which is reported to have a potential role in 
TGF-beta signaling during MSC chondrogenic differentiation (Barry et al., 1999). CD73 
or  ecto-5-nucleotidase is known to be involved in bone marrow stromal interactions, 
MSC migration, potentially and MSC modulation of adaptive immunity (Barry et al., 
2001; Eckle et al., 2007; Ode et al., 2011). The function of the CD90 (Thy1 antigen) in 
MSC regulation is not fully elucidated. It has been postulated to mediate cell-cell 
interactions and participate in the adhesion of polymorphonuclear monocytes, leukocytes 
to microvascular endothelial cells and fibroblasts (Saalbach et al., 2000; Haeryfar and 
Hoskin, 2004)  
 As for CD44, it is a multifunctional glycoprotein which is expressed in all the 
stromal cells. It commonly regulates cell–cell adhesion and migration. Its most noted 
ligands include hyaluronan and osteopontin. It has been recently proposed to mark 
several types of cancer stem cells. Its numerous other functions include roles in matrix 
assembly and apoptosis resistance (Spaeth et al., 2013).  
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 There are many reports on the significant variability in the expression of many of 
the markers mentioned above due to variation in either tissue source, the method of 
isolation or culture and species differences (Baddoo et al., 2003; Javazon et al., 2004). 
MSCs from different species do not always have the same expression pattern of surface 
molecules as those on human cells; for example, although human and rat MSCs are 
known to be devoid of  the endothelial cell marker CD31 and the hematopoietic marker 
CD45, there are contradicting reports with regards to CD34. Variable expression of CD34 
has been reported on murine MSCs (Peister et al., 2004). As for CD90, a strong pattern 
of expression was found in almost all the species tested but was found absent on MSCs in 
goats and sheep. Also, CD90 expression was postulated to be more restricted to humans 
when compared to mice (Boxall and Jones, 2012). In fact, CD90 was found to have 
different patterns among different strains of mice due to the variable  expression of two 
alternative CD90 antigens (CD90.1/Thy1.1 or CD90.2/Thy1.2), which only differ by one 
amino acid (Rege and Hagood, 2006). 
 
1.3.3. Multipotenty potential of MSCs 
 The ability to differentiate along several mesenchymal cell lineages is a unique 
feature and fundamental property of MSCs. MSC potency extends beyond the 
conventional mesodermal lineages (osteoblasts, adipocytes and chondrocytes) and 
includes differentiation into liver, muscle, kidney, neural, skin, and cardiac cells (Arthur 
et al., 2009). However, the differentiation of MSCs varies significantly and depends on 
the tissue source. Also, in vitro propagation leads to a substantial loss of multi-
potentiality as a result of cellular senescence. Studying the multipotency of MSCs has 
allowed researchers to understand more about the differentiation pathways of various 
lineages for tissue engineering and therapeutic purposes. For an effective clinical 
application, the ability to change biological effectors to either maintain or prevent a 
differentiation program is necessary. However, the identification of specific signaling 
networks and regulatory genes that regulate MSC differentiation to different lineages 
remains a challenge (Kolf et al., 2007; Via et al., 2012). 
 Chondrogenesis is a complicated and well organized event which requires 
commitment of MSCs, followed by their differentiation into chondrocytes (Akiyama, 
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2008). In vitro differentiation of MSCs into a chondrogenic lineage has been attributed to 
many factors; co-culture with cartilage through exposure to growth factors, or via the 
overexpression of specific genes such as Sox9 which has been postulated to promote 
chondrocytic differentiation. In fact, inducing ectopic expression of Sox9 in mice 
upregulates type 2 collagen (Bell et al., 1997; Tsuchiya et al., 2003). TGFβ is another 
key molecule implicated to have a role in chondrogenic differentiation. Interestingly, the 
low chondrogenic potential in adipose tissue-derived MSCs (AT-MSCs) was overcome 
by inducing the overexpression of TGFβ receptor1 (Hennig et al., 2007). Needless to say, 
the ability to promote and control chondrogenic differentiation in MSCs has significant 
clinical application for treating conditions such as intervertebral disc degeneration 
(Richardson et al., 2006). 
 The generation of osteoblasts by mesenchymal stem cells has been well 
documented. Several molecules have been implicated in the control of osteogenic 
differentiation; Wnts are postulated to be strong modulatory elements where their high 
endogenous levels are correlated with enhanced osteogenesis (Gaspar and Fodde, 
2004). Also, a regulatory network of Bmps, Runx2 and TNFα was found to regulate 
osteogenesis (Kaneki et al., 2006). These different regulatory elements could serve as 
potential targets for MSC-based bone tissue engineering.  
 MSC capacity to generate adipocytes has been extensively studied. PPAR-γ is 
among the key molecules thought to regulate the function of many adipocyte specific 
genes (Rosen and Spiegelman, 2000). Adipogenesis can be induced either through the 
exposure to exogenous factors or by culturing MSCs in adipogenic media containing 
insulin and dexamethasone. Molecules known to regulate adipogenesis could serve as 
possible candidates for the treatment of obesity (Farmer, 2005; Yin et al., 2010).  
 The differentiation potential of MSCs to different lineages has varied 
considerably among different sources. BM-MSCs have shown differentiation potential 
towards osteoblasts, chondrocytes, adipocytes, tenocytes and vascular smooth muscle 
cells. Umbilical cord blood-derived MSCs have shown the ability to give rise to 
osteoblasts, chondrocytes, adipocyte, skeletal muscle cells, endothelial cells, 
cardiomyocytes-like cells and neurons. However, periosteum-dervied MSCS have the 
capacity to generate only osteoblasts and chondrocytes (Via et al., 2012). 
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1.3.4. Expression of pluripotency markers 
 Mesenchymal stem cells possess similar properties to embryonic stem cells in 
terms of their self renewal and differentiation capacities, although to a less extent in 
MSCs. Therefore, the expression of pluripotency markers has been widely investigated in 
MSCs to determine if they regulate their stemness properties. Many studies have 
demonstrated the expression of pluripotency factors in MSCs and their role in regulating 
MSCs properties. One study reported the positive expression of OCT4, SOX2 and 
NANOG in human MSCs and that it controls the same regulatory circuitry of ESCs. 
Also, it reported that Oct4 regulated MSC cycle progression (Greco et al., 2007). In 
2014, a study reported that adipose tissue-derived MSCs express Oct4, Sox2 and Nanog 
(Taha et al., 2014). However, the expression and role of pluripotency markers have been 
controversial topics. Other studies reported that human MSCs express NANOG but not 
OCT4 or SOX2 (Lengner et al., 2007; Pierantozzi et al., 2010). 
 
1.4.Mesenchymal stem cells in therapy 
 The multipotency potential of MSCs together with its presence in a variety of 
different tissues strongly poses a critical role of MSCs in injury healing. MSCs become 
recruited for growth, wound healing, and replacing cells. Therefore, they have been 
shown to have great promise in the treatment of tissue injury and degenerative diseases. 
Transplantation of autologous bone marrow mesenchymal stem cells (BM-MSCs) in the 
digestive system, improved liver function in liver cirrhosis and liver failure patients 
caused by hepatitis B (Kharaziha et al., 2009; Peng et al., 2011). Also, BM-MSCs have 
been shown to have strong therapeutic potential in the musculoskeletal system. In fact, 
several studies have reported the effectiveness of BM-MSCs in the regeneration of 
diabetic critical limb ischemia, periodontal tissue defects and burn-induced skin defects 
(Rasulov et al., 2005; Yamada et al., 2006; Lu et al., 2011). Preclinical studies have 
shown the effectiveness of human MSCs in treating myocardial infarction and cornea 
damage by reducing inflammation and promoting tissue reconstruction (Lee et al., 2009; 
Roddy et al., 2011). The ability of MSCs to regulate immune responses is the reason 
behind their use in immune disorders. For example, MSCs have been successfully 
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utilized to reverse graft-versus-host disease (GvHD) in patients receiving bone marrow 
transplantation (Müller et al., 2008; Prasad et al., 2011). 
 
1.5.Isolation techniques of MSCs 
 To date there are a variety of protocols published on the different isolation 
methods for MSCs. However, they report non-comparable data. The first and simplest 
method used involves adherence to plastic property of MSCs. A modification of this 
technique included the density centrifugation of BM like Ficoll and Percoll that involve 
the separation of a mononucleated fraction of BM which contains MSCs. Afterwards, 
plastic adherence is utilized resulting in a population of MSCs (Lennon and Caplan, 
2006). For sources other than the bone marrow like cartilage and fat, collagenase 
digestion process is often used as an enzymatic treatment to isolate the cells from tissues. 
Collagenases are enzymes capable of cleaving the peptide bonds in the triple helical 
collagen molecule. Accordingly, cells can be easily cleaved from tissues and collected 
(Pountos et al., 2007). Collagenase treatment was found to yield 100 times more MSCs 
compared to BM aspirates (Sakaguchi et al., 2004). However, it was reported that MSCs 
isolated using enzymatic procedures possess a higher metabolic activity and lower 
alkaline phosphatase (ALP) activity which might cause changes in the metabolic profile 
of MSCs (Thomas et al., 2004). The major problem in the previously mentioned 
techniques is the presence of contaminating cells which result in heterogeneity of the 
population.  
 Two similar techniques called the magnetic bead sorting technique (MACS) and 
fluorescence-activated cell sorting (FACS) have been developed to generate pure 
populations of MSCs. Magnetic bead sorting is based on labeling antigens positive for 
MSCs with antibody-coated magnetic beads. Therefore, when a magnetic field is applied, 
the positively labeled cells can be separated (Inokuchi et al., 2005). Fluorescence-
activated cell sorting (FACS) is based on labeling the desired population of cells with one 
or several monoclonal antibodies tagged with a fluorescent dye, cells positive and 
negative for the labeled antibodies can be separated based on the intensity of fluorescence 
they emit (Baumgarth and Roederer, 2000; Tung et al., 2004). However, the 
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limitations of FACS include the high cost and the complicated process of data analysis 
(Jahan-Tigh et al., 2012; Shapiro et al., 2013). 
 Adhesion of MSCs to Extacellular Matrix Proteins (ECM) has been extensively 
studied especially in clinical-based research. ECM is an important part of the cellular 
microenvironment and it plays a major role in deciphering the cell behavior and function 
by governing cell adhesion, migration, differentiation, proliferation and apoptosis 
(Hidalgo-Bastida and Cartmell, 2010). Collagen type I, elastin, laminin, fibronectin and 
vitronectin are the major proteins present in the ECM. Collagen type I is the major 
protein present in the ECM of bone. Laminin is present in basal laminae and they assist in 
cell adhesion. Fibronectin and vitronectin are present in ECM as well as in serum and 
they promote cell adhesion and spreading (Underwood and Bennett, 1989; Mizuno and 
Kuboki, 2001; Mochizuki et al., 2003). Mesenchymal Stem Cells were found to bind to 
ECM proteins collagens, laminins, fibronectin and vitronectin in an integrin-mediated 
fashion (Finne-Wistrand et al., 2012; Roncoroni et al., 2013). Enrichment for cells 
using ECM proteins has been used previously. Adherence to collagen IV has been used to 
enrich for tumour initiating cells in oral cancer. In 2012, collagen type IV was also used 
to enrich and characterize human dermal stem/progenitor cells (Shim et al., 2012; Liang 
et al., 2014). However, to date, the use of extracellular matrix proteins for the enrichment 
of MSCs hasn’t been widely investigated.  
 
1.6. The testis as a new source of MSCs 
 There are very few reports on the isolation of MSCs from the testis; two on 
human derived MSCs (Gonzalez et al., 2009; Chikhovskaya et al., 2013) and one 
isolated from the marmoset monkey (Eildermann et al., 2012). All studies reported the 
multipotency differentiation potential of the isolated cells and expression of MSC surface 
markers. Also, they report that testis-derived MSCs are not of germ cell origin. 
Chikhovskaya and colleagues reported culturing human testis-derived stem cells which 
grew in the form of colonies but Gonzalez et al. and Eildermann et al. reported the 
appearance of fibroblast-like cells. Also, Chikhovskaya reported that the isolated cells 
were cultured for 4 to 6 passages in 50 days but Gonzalez reported that the isolated MSCs 
could be cultured for 17 passages. However, Eilderman did not elaborate on the 
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proliferation pattern of the isolated cells. In conclusion, the available studies on the 
isolation of MSCs from the testis are few and report some inconsistent data which 
generates the need to conduct more studies on testis-derived MSCs from different sources 
to understand more how they behave and proliferate in vitro (Gonzalez et al., 2009; 
Eildermann et al., 2012; Chikhovskaya et al., 2013). 
 
1.7. Objectives and Experimental Plan 
 The main objective of the proposed study is to utilize the mouse model, for the 
first time, to isolate and culture testis-derived Mesenchymal Stem Cells (tMSCs). 
To achieve this purpose, an enrichment technique was utilized based on adhesion 
of MSCs to laminin followed by subsequent propagation on gelatin-coated dishes. 
 The second aim of our study is to characterize the isolated cells for cell surface 
markers characteristic of MSCs (CD44, CD73 and CD29) and hematopoietic cells 
(CD45), compare their expression levels with the starting population (Testicular 
cell suspension) and investigate the effect of serial passaging on these markers.  
 The third aim was to investigate the origin of the isolated cell population by 
investigating the expression of the germ cell marker Vasa.  
 The last objective of our study was to assess the expression of the pluripotency 
markers Nanog and Oct4 in tMSCs. 
 
 To achieve our objectives, testes of CD-1 male juvenile mice were harvested and 
exposed to a series of enzymatic digestion and plating steps to enrich for tMSCs. The 
enriched population was cultured in vitro and aliquots from every passage were processed 
for RNA analysis to assess the expression levels of genes of interest. Cell suspensions 
from early passages were analyzed by flow cytometry. 
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2. Materials and Methods 
2.1.Animals 
 Male CD-1 Swiss albino mice (4-5 weeks old) were obtained from the 
experimental animal research unit at Theodor Bilharz Research Institute (TBRI, Giza, 
Egypt). At the institute, animals were maintained on a standard commercial pellet diet 
(El-Kahira Company for Oils and Soap, Cairo, Egypt). The animals were given carrot, 
lettuce and milk as a source of vitamins. Animal experiments were carried out according 
to internationally valid guidelines.  
2.2.Primary Cell Cultures 
2.2.1.  Preparation of testicular single cell suspensions 
 Three independent enrichment experiments were performed utilizing a total of 12 
male mice. Mice were euthanized and dissected. Then, testes were harvested and washed 
three times in sterile filtered Phosphate Buffered Saline (PBS) (Lonza, Switzerland). For 
each experiment, the testes of 4 mice were pooled together. In sterile conditions, testes 
were placed in a 100 mm cell culture dish (Corning, USA) and cut into small pieces using 
a sharp blade. 
 The cut fragments were exposed to a two-step enzymatic digestion procedure 
(Guan et al., 2009). Briefly, fragments were incubated with sterile filtered 1 mg/ml 
collagenase type IV (Worthington Biochemical Corp, USA) in Dulbecco’s Modified 
Eagle Medium (DMEM, GIBCO, USA) (4-5 ml/ mouse) for 20 minutes at 37°C in a CO2 
incubator (Shellab, USA) or until the tubules dispersed. The resulting fragments were 
centrifuged using (Eppendorf, Germany) at 200xg for 5 min at 15–25°C, then washed 
with PBS, centrifuged again and incubated with 3ml/mouse of trypsin (GIBCO, USA). 
After incubation for 5 minutes at 37°C, the tubule fragments were dispersed by pipetting 
and trypsin was inactivated by adding serum-containing media. The resulting mixture 
was filtered using a sterile 70-μm pore size Nylon mesh (BD Bioscience, USA). Aliquots 
of the testicular cell suspension were taken for molecular testing. 
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2.2.2. Enrichment for tMSCs using laminin-coated dishes 
  To prepare laminin coated dishes, 60 mm cell culture dishes were incubated with 
2 ml of laminin solution (20μg/ml in PBS, Sigma-Aldrich Co., USA) for at least 3 hours 
in 37°C incubator. After removal of laminin, dishes were washed with PBS. Testicular 
cell suspensions were plated on laminin-coated dishes at the density of 4-5x10
6 
cells /dish 
to enrich for tMSCs. After incubation for 15-20 minutes at 37°C in a CO2 incubator, the 
adherent cells were washed gently with PBS, trypsinized and seeded on 6-well plates 
coated with 0.1% gelatin solution (Sigma, USA) at the seeding density 70,000 cell/ cm
2
 
in tMSC culture media. A pilot study was performed by culturing non-laminin bound 
fraction of testicular cell suspension under the conditions mentioned above. The steps for 
tMSCs enrichment have been summarized in a schematic diagram (Figure 1). 
 tMSC primary cells were cultured in complete media composed of Minimum 
Essential Medium (α-MEM, GIBCO, USA) supplemented with 1% Fetal Bovine Serum 
(FBS, GIBCO, USA), 5%  penicillin/streptomycin (GIBCO, USA), 1X Non-Essential 
Amino Acids (NEAA, GIBCO, USA), 1X β-Mercapto Ethanol (β-ME, 10 mM, Serva, 
Germany), 0.2% Bovine Serum Albumin (BSA, GIBCO, USA), 1X Bottenstein’s N2 
supplement (Life Technologies, USA), 20 ng/ml recombinant rat Glial Cell Line-derived 
Neurotrophic Factor (GDNF, R&D Sciences, USA), 10 ng/ml  basic Fibroblast Growth 
Factor (bFGF, Life Technologies, USA) and 1000 U/ ml recombinant human Leukemia 
Inhibitory Factor (LIF, Life Technologies, USA). Upon reaching 80-90% confluence 
corresponding to ≈50,000 cells/cm2, Cells were trypsinized and split at the ratio 1:3 or 1:4 
on gelatin-coated dishes. Cultured cells were regularly examined for morphological 
characterization and tracking morphological changes while passaging using inverted 
microscope (Olympus 1X70, USA).  
 
2.3.Viable Cell Count 
 For tMSCs, the viable cell count was determined at every passage by trypan blue 
exclusion staining. For each count, 20 µl of cell suspension was stained with 20 µl 0.4% 
trypan blue (Sigma, USA) and viable cells were counted using a hemocytometer (Hausser 
Scientific, USA). 
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2.4.Population Doubling Time (PDT) 
 To analyze the growth kinetics of tMSCS, the PDT was calculated at every 
passage according to the following equation: TD = tplog2/(logNt-logNo). Where Nt is the 
number of cells harvested, whereas No is the number of cells seeded, and t is the time of 
the culture (in hours). The trypan blue exclusion test was used to count the cells with the 
hemocytometer. 
 
2.5.Reverse Transcription-Polymerase Chain Reaction (RT-PCR) 
 Total RNA was extracted from cell pellets of tMSCs at different passages (P0, P1, 
P2, P3, P4, P5 and P6) using Trizol® (Invitrogen, USA) as per manufacturer's protocol. 
RNA was extracted from pellets of the starting population (Testicular cell suspension) 
prior to enrichment for comparison. Then, RNA was dissolved in diethylpyrocarbonate 
(DEPC) treated water and was quantified at A260mm using Shimadzu spectrophotometer 
UV-1800. cDNA was synthesized from 1 μg of RNA using RevertAID™ First Strand 
cDNA synthesis kit (Fermentas, USA) according to the manufacturer’s instructions.  
 An aliquot of 1 µl of the cDNA was then added to the reaction mixture using 
mouse specific forward and reverse primers. The sequences of the primers used to 
analyze the following genes; CD44, CD73, CD29, CD45, Nanog, Oct4, Vasa and the 
loading control β-actin are listed in Table 1. The mixture consisted of 1 µM of each 
primer, 2 μl of 10X DreamTaq Buffer, 1 μl of 10 mM dNTP Mix and 1U of DreamTaq 
DNA Polymerase (Fermentas Inc, USA). The reaction was completed with nuclease free 
water to form a total mixture of 20 μl. A negative control was prepared for each run 
without the template cDNA to detect any contamination or non-specific amplification in 
the reaction. PCR reaction mixture was then thermal cycled on a Veriti® Thermal Cycler 
(Applied Biosystems, USA) using primer-specific cycle programs.  
 The amplified PCR products were electrophoresed on 1.5% agarose gel. For 
amplified products of Nanog, 12% acrylamide gel was used to resolve a difference of 
three base pairs between two amplicons. Acrylamide gel was prepared as follows: 3.2 ml 
Acrylamide/bisacrylamide 29.2 :0.8  was added to 2 ml Distilled  water, 2.6 ml 1.5 M 
Tris pH 8.8, 135 µl 10% Ammonium Persulfate (APS, ThermoScientific, USA) and 15 µl 
Tetramethylethylenediamine (TEMED Plus One, GE Healthcare, USA) with total volume 
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of 8 ml. The gels were visualized with ethidium bromide (Sigma, USA) and 
photographed under UV light using GelDoc (Bio-rad, USA). The resulting images were 
assessed by densitometric analysis of the bands using ImageJ software (NIH, USA). The 
intensity of each band was normalized against its corresponding β-actin band to compare 
values between samples. For Nanog variants, the densities of the two bands (580 bp and 
583 bp) were compared relative to each other as percentage means. 
Spidey sequence alignment and primer blast tools were used to determine the structure of 
the different alternatively spliced variants in Nanog and the amplified sequences. 
Table 1. Sequences of primers used in the study, amplicon size and cycling 
conditions. 
Gene Sequence 
Amplicon 
size 
Annealing 
Temperature 
No. 
of 
cycles 
Mouse 
CD44 
F-5'TCCAGGGGGAGTTCCCGCAC3'                                    
R-5'GGAGGGTCCCAGCTCCCAGCTCCCAGG3' 
469 bp 67°C 32 
Mouse 
CD73 
F-5'TTGGCAAATACCTGGGCTAC3'                                                                        
R-5'AGGTTTCCCATGTTGCATTC3' 
241 bp 47°C 34 
Mouse 
CD29 
F-5'GTGACCCATTGCAAGGAGAAGGA3'                    
R-5'GTCATGAATTATCATTAAAAGTTTCCA3' 
271 bp 60°C 33 
Mouse 
CD45 
F-5'TGCTCCTCAAACTTCGACGGA3'                        
R- 5'CTGCCAAAAGTCACCGATCGT3' 
655 bp 62°C 32 
Mouse 
Nanog 
F-5'GGCTGCCTCTCCTCGCCCTT3'                               
R-5'CCAAGGCTGGCCGTTCCAGG3' 
583 bp 
580 bp 
66°C 35 
Mouse 
Oct4 
F- 5'TGGTGCAGGCCCGGAAGA3' 
R-5’AGCATCCCCAGGGAGGGC3’ 
429 bp 63°C 33 
Mouse 
Vasa 
F-5'GGTCCAAAAGTGACATACC  
R-5'TTGGTTGATCAGTTCTCGAGT3' 
420 bp 57°C 25 
Mouse 
B-actin 
F-5'ACGCAGGATTTCCCTCTCAGC3'                       
R-5'GGCCCAGAGCAAGAGAGGTAT3'  
460 bp 60°C 27 
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2.6.Flow Cytometry 
 Testiscular cell suspensions and cultured tMSCs were stained with antibodies for 
immunophenotypying using fluorescence-activated cell sorting (FACS) analysis. Briefly, 
tMSCs were harvested using trypsin for 5 min at 37°C, after deactivation, approximately 
5 × 10
5
 cells were recovered by centrifugation at 450 xg for 5 mins. Afterwards, cells 
were resuspended in ice-cold PBS as a washing step, centrifuged again and incubated 
with PE-conjugated CD44 antibody (Beckman Coulter, Mexico) and FITC-conjugated 
CD45 antibody (Beckman Coulter, Mexico). Cells were stained for 30 minutes at 4°C in 
the dark with the antibodies. After washing using PBS, samples were analyzed on a 
COULTER Epics XL flow cytometer (Beckman Coulter, USA) and at least 10,000 events 
were acquired for each population. Data acquisition and analysis were performed using 
XL SYSTEM II™ software (Beckman Coulter, USA). All experiments included negative 
controls that represented unstained cells to adjust threshold positivity. 
 
2.7.Statistical Analysis 
 Data are presented as mean±SD of two or more independent experiments. 
Comparisons were carried out using one-way analysis of variance (ANOVA) followed by 
Tukey– Kramer’s test for post hoc analysis. Statistical significance was acceptable to a 
level of P<0.05. To compare the different expression patterns of Nanog transcript 
variants, two-way ANOVA was used followed by Bonferroni’s test for post hoc analysis. 
All statistical analyses were performed and plotted using GraphPad Prism software, 
version 5.00 (GraphPad Software, USA). 
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Figure 1. Representation of the cell isolation procedures, culture conditions and 
plating densities for the isolation of tMSCs. 
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3. Results 
 
3.1.Enrichment for  testis-derived Mesenchymal Stromal Cells (tMSCs) 
 A total of 12 male Juvenile CD-1 mice (4-5 weeks) with average weight 
7.27±1.63 (gm±SD) were sacrificed in three independent experiments. Following manual 
teasing and enzymatic digestion with collagenase type IV and trypsin, the cellular 
suspension consisted of free and single cells. The viable cell count of the cell suspension 
yielded an average count of 2.34±0.49 (x10
6
±SD)/ paired testes, where the cell viability 
was found more than 90% throughout the experiments. Incubating the testicular cell 
suspension on laminin-coated dishes at the plating density ≈2.25x105/cm2, yielded an 
average of 3.71±0.81 (x10
5 ±SD)/ paired testis adherent cells constituting ≈16% of the 
initial cell suspension. Details of mice weights and cell yields are summarized in Table 2. 
 Laminin-bound cell fraction was seeded on gelatin coated dishes in tMSC media. 
Cells started to adhere around 12 hours post plating and spindle-shaped fibroblast-like 
cells were noticed to appear 24-36 hours post plating (Figure 2A, 2B). Media was 
changed after 48 hours to remove non-adherent cells and after around 4 days from the 
start of enrichment experiments, tMSCs reached 80%-90% confluence which comprised 
around 50,000 cells/cm
2
. At this stage,
 tMSCs were termed “Passage 0” and were ready 
to be propagated. 
3.2.Culturing tMSCs 
 At passage 0, cells were morphologically found to be highly heterogeneous 
having both round and spindle shaped cells (Figure 2 A). Heterogeneity of the population 
seemed to decrease with subsequent passaging becoming nearly homogeneous at passage 
2. tMSCs were cultured in vitro for 4-9 passages, the cells were plastic adherent and 
during early passages from passage 1 to passage 5 (Figure 2, C-F), they maintained the 
bipolar spindle-shaped morphology. Upon confluency, the monolayer exhibited a 
constant orientation and whirling tendency. Interestingly, colonies resembling those of 
embryonic stem cells (ESCs) appeared in confluent cultures of passages 1 and 2 (Figure 
3A and 3B). However, they disappeared with later passages. Although, Population 
Doubling Time (PDT) gradually increased with subsequent passaging (Figure 4), tMSCs 
 19 
 
of early passages (1-5) exhibited a relatively high proliferation pattern with average PDT 
(47.7±10 hr.). The average time it took for tMSCs to reach 80-90% confluence was 
around 3-5 days depending on the seeding density. 
 Starting with passage 6 (Figure 2G), a change in morphology started to appear 
that was more prominent in later passages (P7-P9). Gradually, cells showed an irregular 
morphology, they became flattened, enlarged with circumscribed nucleus and increased 
debris in the medium (Figure 2H). Also, PDT was increasing with later passages until it 
became significantly different at passage 7 compared to passage 4 (Figure 4). On the 
other hand, although fibroblast-like cells appeared in the non laminin-bound fraction, 
they couldn’t be propagated beyond passage 1. 
 
Table 2. Mice weights and cell yields generated throughout experiments 
 
Experiment 
 
Weight 
(gms) 
Average 
weight 
(gms) 
Cell yield/ 
paired 
testes 
Seeding 
density 
in 
laminin 
Cell yield after 
laminin 
enrichment/ 
paired testes 
 
1 
6.8  
5.82 ±0.74 
 
1.9 x10
6
 
 
2
.2
5
x
1
0
5
/c
m
2
 
 
2.85 x10
5
 5.8 
5 
5.7 
 
2 
6.9  
7.1 ±0.77 
 
2.87 x10
6
 
 
4.45 x10
5
 6.4 
6.9 
8.2 
 
3 
10.1  
8.9 ±1.49 
 
2.25 x10
6
 
 
3.85 x10
5
 9.94 
6.86 
8.7 
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Figure 3. Morphological examination of a tMSC colony. (A) Low (x100) and (B) high 
power (x400) images of a tMSC colony (arrows) at passage 1, respectively. 
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Figure 4. Figure 4. Population Doubling Time (PDT) of tMSCs. A significant increase 
in PDT started to appear at passage 7.  Data are presented as mean±SD of two 
independent experiments. P: Passage. * significantly different at p < 0.05. 
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3.3.Expression patterns of MSC surface markers at the RNA level 
 RT-PCR data revealed the high expression of CD44 steady state mRNA levels in 
tMSCs from passage 0 to passage 6 (Figure 5). Interestingly, the expression levels were 
significantly higher than the testis with ≈9.6 folds at passage 0. The expression pattern 
remained elevated and at comparable levels throughout different passages. 
 
 
Figure 5. Expression of CD44 surface marker in tMSCs during continuous passages 
by RT- PCR. (A) Representative RT-PCR gel image  for CD44 (469 bp) and the loading 
control β-actin (460 bp). (B) Bar chart representing normalized expression values relative 
to the loading control. Data are presented as mean±SD of at least two independent 
experiments, P: Passage. *: significantly different at p < 0.05, **: significantly different 
at p<0.01. 
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 CD73 and CD29 transcript levels revealed the positive expression of both markers 
(Figures 6 and 7). Both markers displayed no significant change in their expression from 
the testis. A gradual decrease in expression pattern of CD73 was noticed until it became 
significantly low at passage 6 compared to passage 4 (Figure 6). CD29 maintained a 
relatively elevated expression pattern throughout different passages until it sharply 
decreased at passage 6 and became significantly different from the previous passages 
(Figure 7). 
 
Figure 6. Expression of CD73 surface marker in tMSCs during continuous passages 
by RT- PCR. (A) Representative RT-PCR gel image for CD73 (241 bp) and the loading 
control β-actin (460 bp). (B) Bar chart representing normalized expression values relative 
to the loading control. Data are presented as mean±SD of at least two independent 
experiments, P:Passage. *: significantly different at p < 0.05, **: significantly different at 
p <0.01. 
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Figure 7. Expression of CD29 surface marker in tMSCs during continuous passages 
by RT- PCR. (A) Representative RT-PCR gel image for CD29 (271 bp) and the loading 
control β-actin (460 bp). (B) Bar chart representing normalized expression values relative 
to the loading control. Data are presented as mean±SD of at least two independent 
experiments, P: Passage. *: significantly different at p < 0.05, **: significantly different 
at p < 0.01. 
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3.4.Expression pattern of hematopoietic cell surface marker (CD45) at the RNA 
level  
 The steady state RNA levels of CD45 cell surface marker were negligible among 
all passages of tMSCs (Figure 8). The expression levels of the testicular cell suspension 
were ≈11.25 folds higher than passage 0 tMSCS. In subsequent passages, CD45 became 
absent or of extremely low levels.  
 
Figure 8. Expression of hematopoietic cell marker in tMSCs during continuous 
passages by RT- PCR. (A) Representative RT-PCR gel image for CD45 (655 bp) and 
the loading control β-actin (460 bp). (B) Bar chart representing normalized expression 
values relative to the loading control. Data are presented as mean±SD of at least two 
independent experiments, P: Passage. ***: significantly different at p < 0.001. 
 
 Taken together, the data obtained for the mRNA steady state levels of CD44, 
CD73, CD29 and CD45 indicated that the status of propagated tMSCs changed after 
passage 5. It seems that tMSCs at P6 assume a different path than mesenchymal stem 
cells. Therefore, to distinguish between the two populations, we classified tMSCs into an 
early stage (from P0 to P5) and a late one (P6). Then, we compared both stages to each 
 26 
 
other and to the testis. CD44 had significant higher expression in tMSCs when compared 
to the levels of testis. In tMSCs, the pattern of expression of CD44, unlike CD73 and 
CD29, remained elevated throughout the tested passages. CD73 and CD29 showed 
comparable expression levels in the testis and early tMSCs, while CD45 had a significant 
higher expression in testis over tMSCs. 
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Figure 9. Graphical representation of the steady state RNA levels of CD44, CD73, 
CD29 and CD45 in testis, early tMSCs and late tMSCs. Early tMSCs represent the 
average expression levels of passages 0 to 5, while late tMSCs represent passage 6. Data 
are presented as mean±SD of at least two independent experiments where 1 μg of RNA 
was consistently used. Expression values are normalized relative to the loading control 
(β-actin). 
Table 3. Significant differences of the mean expression values of surface markers 
(CD44, CD73, CD29 and CD45) between testis, early tMSCs and late tMSCs. 
Marker Testis and Early 
tMSCs 
Testis and Late 
tMSCs 
Early and late 
tMSCs 
CD44 *** *** Ns 
CD73 Ns *** ** 
CD29 Ns *** *** 
CD45 *** *** Ns 
**: Significantly different at p<0.01, ***: significantly different at p<0.001 
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3.5.Immunophenotyping 
 Immunophenotyping using flow cytometric analysis was performed for the 
mesenchymal stem cell marker CD44 and the hematopoietic cell marker CD45 on 
testicular cell suspensions and tMSCs at passages 1 and 2. Percentages were calculated 
using the Median Fluorescent Intensity (MFI). Data showed that a high percentage of 
tMSCs expressed CD44 cell surface marker (>70 %) while low percentage of cells 
expressed CD45 (<7%) (Figure 10). On the other hand, a low percentage of cells in the 
testicular cell suspensions expressed both markers; CD44 <18% and CD45 <14%, 
detailed percentage means are presented in Table 4. When comparing the percentage of 
cells expressing both markers in tMSCs and testis, CD44 is found to be higher in tMSCs 
by ≈ 4.12 folds while CD45 is found to be lower in tMSCs by ≈0.5 folds. 
Table 4. Percentage means of the immunophenotypic characterization of testis and 
tMSCs by flow cytometry. Data are presented as percentage means of passages 1 and 2 
±SD. 
 CD44 CD45 
Testis 17.5±9.1 13.2±4.2 
tMSCs 72.1±7.9 6.9±1.5 
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3.6.Investigation of the cellular origin of tMSCs 
 To investigate whether tMSCs originated from a germ cell origin or not, we 
assessed the steady state RNA levels of the germ cell marker Vasa at passages 1 and 3. 
RT-PCR data showed the negative expression of Vasa in tMSCs (Figure 11A). Vasa 
displayed significantly low/no expression levels in tMSCs at P1 when compared to the 
high levels of expression in the testis and it was absent in the subsequent passages 
(Figure 11 B). 
 
Figure 11. Analysis of cellular origin of tMSCs by RT- PCR. (A) Representative RT-
PCR gel image for the germ cell marker Vasa (420 bp) and the loading control β-actin 
(460 bp). (B) Bar charts representing normalized expression values relative to the loading 
control. Data are presented as mean±SD of three independent experiments, P: Passage. 
***: significantly different at p<0.001.  
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3.7.Investigation of the transcript levels of pluripotency markers 
 RT-PCR results revealed the lack of expression of Oct4 in tMSCs, while testis 
gave a weak expression (Figure 12). As for Nanog, RT-PCR was performed using 
primers which have four potential targets; they can detect variant 2 at a band of 580 bp 
and variants 1, 3 and 4 at a band of 583 bp (Figure 13). Therefore, the 580 bp amplicon 
reflects the expression pattern of variant 2, but the 583 bp amplicon does not distinguish 
between the expressions of the remaining variants because it amplifies a conserved 
sequence in them. tMSCs expressed Nanog throughout different passages (Figure 14A). 
In the testis, the transcript levels of variant 2 at 580 bp were found to be significantly 
higher than those of the variant(s) at 583 bp with ≈ 9.59 folds. Interestingly, in tMSCs, 
the levels of variant(s) at 583 bp started to increase, meanwhile those of variant 2 
decreased reaching a significant fold change of ≈ 11.98 between the two bands in P3 
(Figure 14B). In general, it was found that variant 2 decreased significantly from testis to 
tMSCs, while the variant(s) at 583 bp displayed a significant increase from testis to 
tMSCs (Figure 14C). 
 
Figure 12. Expression of Oct4 in tMSCs by RT- PCR.  (A) Representative RT-PCR gel 
image for Oct4 (429 bp) and the loading control β-actin (460 bp). (B) Bar chart 
representing normalized expression values relative to the loading control. Data are 
presented as mean±SD of at three independent experiments, P: Passage. *: significantly 
different at p < 0.05.  
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Figure 13. Schematic diagram of alternatively spliced mouse Nanog variants. 
Primers utilized throughout experiments (colored regions) have four possible Nanog 
targets; variants 1, 2, 3 and 4. The amplicon generated from variant 2 is 580 bp. Variants 
1, 3 and 4 generate amplicons of equal size; 583 bp. The sequence amplified from 
variants 1, 3 and 4 is a conserved one.   
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Figure 14. Expression of Nanog transcript variants in tMSCs by RT- PCR. (A) 
Representative gel image of the different expression patterns of variant 2 at 580 bp and 
variant(s) at 583 bp in the testis, P1 and P3. (B) Stacked bar chart representing variation 
in expression of variant 2 at 580 bp and variant(s) at 583 bp, presented as percentage 
means. (C) Bar chart showing the pattern of expression of each band in the testis, P1 and 
P3, expression values are normalized relative to the loading control (β-actin). Data are 
presented as mean±SD of three independent experiments. #: Significant difference 
between variant 2 at 580 bp and variant(s) at 583 bp at p<0.01, Φ: Significant difference 
between variant 2 at 580 bp and variant(s) at 583 bp at p<0.001, **: Statistically 
significant at p<0.01. ***: Statistically significant at p<0.001. 
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4. Discussion 
 Since their initial isolation from the bone marrow in 1967, Mesenchymal stem 
cells have been the subject of interest of many researchers. Over the past decades, the 
research community has been flooded with studies on MSCs isolated from different 
sources and different species. The main focus of these studies was to characterize MSCs, 
expand them in culture, understand more about how they behave in vivo and most 
importantly, investigate their trilineage differentiation potential. MSCs are considered the 
most commonly used stem cells in current clinical applications, because of their low risk 
of developing teratomas, low immunogenicity and they have numerous sources. (Wei et 
al., 2013). 
 One of the major hurdles in MSC research is the low yield of MSCs isolated from 
different sources that might be related to the techniques used for their isolation. 
Conventionally, most researchers use culturing on plastic plates as the primary method 
for isolating and culturing anchorage dependent cells (Zangi et al., 2006). However, 
beside the fact that plastic adherence results in low cell count especially for BM-MSCs, 
the cultured cells reflect heterogeneous populations that often contain contaminating 
cells. To date, several techniques have been developed to obtain pure cultures of MSCs 
by the reduction or elimination of cells other than MSCs or by enriching for MSCs 
(Nadri et al., 2007). Still, the search is ongoing for a simple and efficient method for 
isolating an MSC population with high degree of homogeneity. 
 Few reports have been published recently on the isolation of mesenchymal stem 
cells from the testis. Although, these studies report similar multipotency potential of the 
different isolated populations, their surface marker profiles are not entirely consistent and 
they had little emphasis on the expansion patterns of the cultured cells in vitro (Gonzalez 
et al., 2009; Eildermann et al., 2012; Chikhovskaya et al., 2013). The testis is a highly 
heterogenous population containing a myriad of different cell types like Sertoli, Leydig, 
peritubular myoid, endothelial and many other cell types (Desjardins and Ewing, 1993). 
Needless to say, utilizing an enrichment protocol for MSCs will aid in generating a more 
homogenous population of cells from early passages. 
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 The aim of our study was to isolate MSCs from the mouse testis using a laminin 
based-enrichment method. Then, culture the isolated cells in vivo and investigate their 
surface marker expression profiles. 
4.1.Laminin to enrich for MSCs 
 In our study, we describe a simple method to enrich for MSCs from testicular cell 
suspensions based on positive selection on the ECM ligand laminin. Three out of three 
(100%) cultures of adherent cells generated from the enrichment technique, led to the 
establishment of tMSC cultures that could be successfully propagated for up to 9 
passages. Failure to produce cultures from the non-laminin-bound fraction gave us further 
confirmation that the enrichment technique was successful. The laminin-mediated 
enrichment method is based on the cell binding capacity of laminin towards 
mesenchymal cell types that results in a rapid and simple selection of MSCs from mixed 
testicular preparations. Adhesion to laminin is mediated through interaction with 
integrins found on the surface of MSCs. In fact, studies by Gronthos et al. showed that 
monoclonal antibody against β1 integrin affected the binding of human bone marrow 
stromal precursor cells to laminin (Gronthos et al., 2001).  Also, MSC were found to 
bind with higher efficiency to laminin-111 (the same type of laminin utilized in our 
studies) when compared to fibroblasts (Roncoroni et al., 2013). 
 The homogenous population observed with early passages (passage 2) is 
suggestive that the enrichment technique was efficient. A high yield of cells was 
generated from the laminin selection step, where around 16% of the cells present in 
testicular cell suspensions adhered to laminin. It is expected that this percentage doesn’t 
reflect an entirely pure population of tMSCs based on the presence of a contaminating 
fraction of non-adherent cells in the subsequent culturing steps. The yield of MSCs 
generated, varied significantly among different studies depending on the method of 
isolation. However, it is considered a high percentage when compared to the low yield of 
cells generated by plastic adherence. In fact, several studies showed that MSCs represent 
only 0.01% to 0.001% of nucleated cells generated from bone marrow aspirates isolated 
by plastic adherence (Majors et al., 1997; Muschler et al., 2001; Marcantonio et al., 
2009). In 2010, a modified method was generated to isolate murine bone marrow MSCs, 
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the method involved enzymatic digestion procedures followed by immunodepletion and it 
resulted in an increased yield of cells up to 6.6% (Xu et al., 2010). It is worth mentioning 
that a study was published in 2006 in which Fibrin Microbeads (FMB) were designed to 
isolate and expand a high yield (4.9%) of rat bone marrow–derived Mesenchymal Stem 
cells. This study was based on the high interaction properties of fibrin with MSCs which 
is a similar principle to the laminin-based enrichment (Zangi et al., 2006). 
 Magnetic activated cell sorting (MACS) or fluorescence activated cell sorting 
(FACS) are techniques commonly used for the isolation of MSCs using specific MSC-
surface antigens to select for the cells (Bosio et al., 2009). However, Laminin-based 
enrichment is not considered a highly specific method that selects only for the desired 
cell population. It is expected that the laminin-bound population is not a pure one, but it 
contains other cell types albeit at lower ratios to the original testicular cell population. In 
fact, laminin was found to bind to spermatogonial stem cells (SSCs) which represent a 
rare population in the testis (0.01%). However, SSCs are eliminated by the subsequent 
culture on gelatin-coated dishes since SSCs do not to bind to gelatin (Wu et al., 2009). 
Therefore, laminin enrichment could be regarded as a simple, rapid and cost-effective 
method for generating cell populations enriched with a high proportion of MSCs.  
4.2.Successful propagation of tMSCs 
 tMSCs were successfully cultured in vitro for several passages. The cells 
displayed a morphological profile identical of MSCs reported in the literature (Ahrari et 
al., 2013; Dehghani, 2015). Also, tMSCs displayed clusters or colonies of cells upon 
confluence which is a feature previously reported in testicular multipotent stromal cells 
isolated from the marmoset monkey (Eildermann et al., 2012). Interestingly, tMSCs 
showed an initial shorter lag or adaptation phase compared to those reported in the 
literature. Barberini et al. compared the proliferation patterns of MSCs isolated from 
different tissue sources and found that it took around 11, 7 and 15 days for BM-MSCs, 
AT-MSCs and umbilical cord-derived MSCs (UC-MSCs) to reach confluence, 
respectively (Barberini et al., 2014). As for MSCs isolated from adult human testes, 
Gonzalez et al. reported that the cells required 7-10 days to reach confluence (Gonzalez 
et al., 2009). However, in our study, it took almost 4 days for tMSCs to reach confluence. 
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 During early passages (passages 1 to 5), tMSCs displayed a high proliferation 
pattern with an average PDT of 47.7 hours. Adult human testis derived MSCs displayed 
higher proliferation patterns of average PDT of 33.8 hrs. (Gonzalez et al., 2009). 
However, it is well established that the proliferation patterns of MSCs vary among 
different protocols due to variations in culture media, source of the cells and growing 
conditions. In fact, tMSCs display high proliferation patterns when compared to other 
reports from different sources; the doubling time of human AT-MSCs was found about 4 
days (Mitchell et al., 2006). Also, in a study conducted to compare between the growth 
kinetics of MSCs isolated from different sources, it was found that BM-MSCs, AT-MSCs 
and periosteum derived cells at passage 2 displayed high PDT of 3.99 days, 4.65 days and 
3.55 days, respectively (Tawonsawatruk et al., 2012). 
 The fast establishment of tMSC cultures and their marked high proliferation 
patterns in early passages might be attributed to several factors. Culturing the cells on 
gelatin-coated dishes could have had a potential role, gelatin-coated matrix was 
previously reported to promote the mass production of early-stage bone marrow-derived 
mesenchymal stem cells (Park et al., 2013). Also, gelatin-coated beads were recently 
used in the large scale expansion of Wharton’s jelly-derived mesenchymal stem cells 
(Zhao et al., 2015). 
 One other possible interpretation is the young age of mice we used. Bergman et 
al. previously reported that an increased proliferation rate was noticed in cultures of adult 
mice than in those of young adults, later studies have given evidence that there is an 
inverse relation between the age of mice and the proliferation pattern. Shi et al. looked at 
adipose tissue-derived MSCs in juvenile and adult mice and found that cells isolated from 
juveniles possess better attachment and proliferation than adults. These findings were 
confirmed by another study published by Kretlow et al. in murine bone marrow-derived 
MSCs. (Bergman et al., 1996; Shi et al., 2005; Kretlow et al., 2008). 
 The growth media used throughout the experiments could be another contributory 
factor. The  media utilized throughout our culture experiments was low serum media 
(1%) supplemented with N2 growth supplement and several growth factors (GDNF, LIF 
and b-FGF)  to support the culture and expansion of tMSCs. There is a growing trend in 
 37 
 
research to substitute the conventional high serum-containing media with low or serum-
free media to avoid the problems associated with using serum in MSC culture. Recent 
studies have reported higher proliferation patterns and differentiation potencies in low 
serum or serum free media when compared to serum containing media in culturing MSCs 
derived from human dental pulp and adipose tissue (Ferro et al., 2012; Sato et al., 2015).  
 The use of growth supplements in cell culture media of MSCs is reported to 
compensate for low serum content. Several studies have reported the establishment of 
successful cultures in low serum media containing N2 and B27 supplements to support 
the growth of dental pulp and skin-derived stem cells, respectively (Riekstina et al., 
2008; Bonnamain et al., 2013). Also, the use of growth factors has been studied in 
enhancing the proliferation and self renewal capacities of MSCs. GDNF and b-FGF were 
already reported in culturing human testis-derived MSCs and b-FGF was found 
associated with high proliferation capacities of testis-derived multipotent stromal cells 
isolated from the marmoset monkey (Gonzalez et al., 2009; Eildermann et al., 2012). 
Leukemia Inhibitory Factor is conventionally used in culturing ESCs, it is postulated to 
have roles in maintaining the self renewal state and preventing the differentiation of 
ESCs (Furue et al., 2005). Also, LIF has been previously used with other growth factors 
in culturing Multipotent Adult Progenitor Cells  (Jiang et al., 2002b). 
 We could not follow through the cultures, due to experimental limitations, to 
determine at what passage the cells cease to grow. However, the change in morphology 
observed with later passages (starting from passage 6) together with the significant 
increase in PDT at passage 7 suggests that the cells started entering a senescent or 
stationary phase of proliferation. The morphological changes occurred are typical of the 
Hayflick model of cellular aging. Also, they fall in line with previous studies on aged 
MSCs reporting changes in cell shape and size, the nucleus becomes circumscribed with 
granulated cytoplasm and increased cell debris (Bonab et al., 2006; Wagner et al., 
2008). The time at which senescence occurs, varies among different reports; some studies 
report that senescence starts with later passages like passage 10 and passage 15 in UC-
MSCs and Wharton's Jelly-derived MSCs, respectively (Christodoulou et al., 2013; 
Otte et al., 2013). However, several studies reported results similar to ours; adipose 
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tissue-derived MCSs and BM-MSCs were found to show signs of senescence and a 
marked increase in PDT at passage 6 (Lu et al., 2006; Christodoulou et al., 2013). In 
addition, a study focused on the molecular events lying behind replicative senescence in 
BM-MSCs and reported that senescence occurs starting from the 7
th
 to the 12
th
 passage  
(Wagner et al., 2008).  
4.3. tMSCs show surface marker profile characteristic of MSCs 
 Our results show that tMSCs express surface antigens of MSCs. At the transcript 
level, tMSCs are CD29
+
, CD44
+
, CD73
+
 and CD45
-
. Phenotypic analysis for CD44 and 
CD45 confirmed these results. We chose CD44, Cd73 and CD29 because they are 
markers known to be consistently expressed among different murine MSCs isolated from 
different sources like bone marrow, synovium, adipose tissue, epiphysis and many others 
(Shen et al., 2011; Viero Nora et al., 2011; Cheng et al., 2012; Futami et al., 2012). In 
fact, our surface marker profile falls in line with that of monkey testis-derived stem cells 
which was found to be positive for CD29, CD44, CD49f, CD73, CD90, and CD105 while 
negative for CD31, CD34, CD45, CD117 and CD133 (Eildermann et al., 2012). 
 We investigated the expression of MSCs surface markers in the initiating 
population that is the testicular cell suspension to compare it with tMSCs and see whether 
these markers are specific for tMSCs or expressed by other cell types. CD73 was found 
not to be specific for tMSCs since its transcript levels showed high expression in the 
testis. In fact, in 2010, a study was performed to investigate the expression of CD73 in 
the murine reproductive system and reported that the protein was detected in germ cells 
but not in spermatozoa and in somatic cells: Sertoli cells, peritubular, interstitial cells, 
macrophages and Leydig cells (Martín-Satué et al., 2010). The high transcript levels for 
CD29 (β1-integrin) in the testis revealed that it may not be considered specific for testis-
derived MSCs, previous studies revealed that CD29 was expressed in spermatogenic 
cells; spermatocytes, spermatids, testicular spermatozoa and spermatogonial stem cells 
(Schaller et al., 1993; Shinohara et al., 1999). 
 Transcript levels, confirmed by phenotypic analysis data, revealed the specifity of 
CD44 to tMSCs, since it was found significantly higher in tMSCs than in testis. These 
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data suggest that a small population of testicular cell types expresses CD44 marker and 
that the enrichment process was successful since this small population of cells was 
isolated and propagated to yield high expression levels from passage 0. Also, This 
finding suggests the possible use of CD44 as a specific marker to isolate testis-derived 
MSCs. FACS data revealed that a high percentage of cells expressed the marker, but it 
was not above 90%. This could be attributed to the fact that FACS analysis was 
performed in early passages (P1 and P2). Although this stage of culture should have 
reached a high level of homogeneity, they have not “suffered” from an over-long 
permanence in culture. However, testis-derived multipotent stromal cells isolated from 
the monkey showed similar expression pattern where 62%-94% of the cells expressed 
CD44 (Eildermann et al., 2012). Also, 78% of adipose tissue-derived MSCs at passage 2 
were reported to express CD44 (Pascucci et al., 2011).  
 As for CD45, the lack of expression in tMSCs was expected since MSCs are 
known not to express hematopoietic cell markers. The elevated expression in testis 
compared to tMSCs suggested that there are cell types in the testis, other than tMSCs, 
which express this marker and these cell types do not contribute to the adherent  
monolayer. Also, the slight expression of CD45 in passage 0 suggests the presence of a 
small percentage of these cell types which were filtered out with later passages. Although 
both data from RT-PCR and FACS confirm the higher expression of CD45 in the testis 
when compared to tMSCs, the percentage of CD45 in the testis was much lower at the 
protein levels rather than the RNA. This might be explained by the presence of over 9 
transcript variants for mouse CD45 detected by the used primers but only three encode 
for proteins. Therefore, it is possible that there are certain non-coding variants expressed 
but not detected at the protein level. The low protein levels of CD45 in the testis could be 
further supported by the findings of Mullen TE where cells expressing CD45 were rarely 
found in the testicular interstitium. Also, CD45 was found to be expressed by testicular 
macrophages which represent only 12% of the interstitial cells of the testis (Dirami et al., 
1991; Habasque et al., 2002; Mullen Jr et al., 2003). 
 Next, we aimed to investigate the effect of serial passaging on the expression of 
mesenchymal stem cell markers. Our results indicate that CD44 expression is not affected 
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with passaging. However, CD73 and CD29 expression is down regulated with aging of 
cells especially at passage 6 which appears to be in consonance with morphological and 
growth kinetics data. Reports have shown contradicting data regarding which markers are 
affected by senescence. In a study conducted by Zhaung Y comparing early (P3) and late 
(P15) passages of umbilical cord-derived MSCs (UC-MSCs), it was concluded that aging 
does not influence the expression of the tested MSC markers including CD44, CD73 and 
CD29. On the contrary, Wagner W et al. found that early passages (P3) of bone marrow-
derived MSCs express much higher levels of MSCs markers than late passages (P12) 
which also included CD44, CD73 and CD29. However, our data might be in line with 
data of Cheng C et al. where it was found that the expression of some markers decrease 
with senescence such as CD73, CD166 and Sca-1, while other markers maintain constant 
levels of expression like CD44, CD29 and CD105. Also, It is possible that CD44 is 
affected by passaging at later stages and not from the start of senescence. (Wagner et al., 
2008; Cheng et al., 2012; Zhuang et al., 2015). Collectively, our data suggest that 
tMSCs started to undergo a stage of cellular senescence at passage 6 and this stage 
affected the expression of some MSC markers like CD73 and CD29. For this reason, we 
classified tMSCs into early and late stages to distinguish the phase at which cells start to 
age.  
4.4.tMSCs are not of germ cell origin 
 VASA is known to be a specific marker for germ cells in both humans and mouse 
(Castrillon et al., 2000; Tanaka et al., 2000). Our data on the lack of expression of Vasa 
in tMSCs fall in line with previously published data on testis-derived MSCs isolated from 
the human and marmoset monkey. In fact, these reports postulate that testis-derived 
MSCs originate from the interstitial stoma of the testis and they do not represent any of 
the testis specific cell types, i.e.; Leydig, Sertoli, Myoid and germ cells (Eildermann et 
al., 2012; Chikhovskaya et al., 2013). It is worth mentioning that the lack of expression 
of germ cell marker further proves the homogeneity of the propagated population from 
early passages and the good enrichment for MSCs cells. 
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4.5.Expression of pluripotency markers 
 MSCs represent a source of adult stem cells endowed with a long-lasting but 
finite proliferation potential, and they can differentiate toward multiple mesodermal 
lineages. Researchers attempt to investigate the expression of pluripotency markers in 
MSCs and see whether they govern their unique properties or not. In our study, tMSCs 
showed positive expression of Nanog. However, they lack the expression of Oct4 which 
contradict previous reports on the expression of Oct4 and its functional role in 
maintaining MSC properties (Izadpanah et al., 2006; Tsai et al., 2012). Also, Gonzalez 
et al. reported that human testis-derived MSCs express NANOG, OCT4 and SSEA4. 
None the less, our data support previously published reports indicating that MSCs 
isolated from the bone marrow, adipose tissue and cardiac tissue were found to express 
NANOG but not OCT4 nor SOX2 (Pierantozzi et al., 2010). Also, Lengner CJ reported 
in a study conducted on stem cells isolated from several somatic tissues that Oct4 is 
dispensable for both self-renewal and maintenance of somatic stem cells in the adult 
mammal (Lengner et al., 2007). 
 Mouse NANOG is a protein involved in the self renewal and maintenance of the 
undifferentiated state of MSCs, it has 4 different alternatively spliced variants (variants 1, 
2, 3 and 4) and 3 different isoforms (1, 2 and 3) where variants 3 and 4 encode for 
isoform 3. Our data suggest that tMSCs, unlike the testis, express low levels of Nanog 
variant 2. A high expression was noticed at the 583 bp band and it was low in the testis. 
However, this band can detect variants 1, 3 and 4. Therefore we couldn’t determine 
which of these variant(s) contributes to the pattern observed. There are few reports on the 
expression patterns of different Nanog variants. Das et al. conducted several studies on 
NANOG splice variants in human and mouse ESCs and reported the observed variation 
in expression ratios of different transcripts. (Das et al., 2011; Das et al., 2012). Another 
study reported the identification of a new variant of human NANOG which is highly 
expressed in multipotent adult progenitor cells (MAPC). The variation was found 
between the homeodomain and the tryptophan repeat (WR) regions of the full length 
sequence. However, this variant had similar activity to the full length one (Kim et al., 
2005). It is possible that the variant(s) at 583 bp play a role in regulating the properties of 
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tMSCs unlike variant 2. Also, the high expression of variant 2 in testicular cell population 
suggests that there are cell types, other than tMSCs which express variant 2 more than the 
remaining variants.  
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5. Conclusions and Future Recommendations 
5.1.Conclusions 
 Up to our knowledge, this is the first study to report the isolation of mesenchymal 
stromal cells from the mouse testis. In our study, we describe a simple and rapid laminin-
based technique to enrich for MSCs. The isolated cells were successfully cultured in vitro 
and displayed morphological properties and marker profiles similar the ones reported for 
MSCs.  
 The high yield of cells isolated and the high proliferation pattern in early passages 
might suggest that the cells can be expanded to therapeutically necessary levels. 
Examining the changes in morphology, PDT and expression pattern of MSC markers 
allowed us to pinpoint at what stage the cells enter senescence. This is the first study to 
report the variation in expression of Nanog variants in tMSCs. This finding sheds the 
light on the possible use Nanog variants as specific markers for MSCs.  
5.2.Future Recommendations 
 The scope of research that can be done to complement this study is huge. In fact, 
this study is only the start of many experiments to be conducted on a promising cell type. 
Multipotency is a golden criterion for MSCs, inducing the differentiation of tMSCs to 
adipocytes, osteoblasts and chondrocytes is crucial to assess their stemness. Also, 
immunophenotyping needs be done on other markers to confirm our data and compare 
the marker profile of tMSCs with those of other testis-derived MSCs reported in the 
literature. Senescence can be thoroughly studied in late passages through the assessment 
of senescence-associated β-galactosidase (SA-b-gal) expression. Experiments targeting 
each Nanog variant alone will be useful to determine which of the three variants (1, 3 or 
4) contribute more, in terms of expression, to tMSCs. Also, extrapolating the laminin-
based enrichment method to isolate MSCs from other sources will be useful to ensure the 
reproducibility of this technique. In addition, in vivo studies using animal disease models 
can be done to assess the therapeutic potential of tMSCs.  
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